- Price
- $1.14
- Day
- -2.16%
- Mkt Cap
- $70.28M
- 52W Range
- $1.02 – $1.95
- Volume
- 682.9K
- Beta
- 1.28
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Connor Clark and Lunn Investment Management Ltd. bought a new stake in Pliant Therapeutics, Inc. (NASDAQ: PLRX) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 536,081 shares of the company's stock, valued at approximately $611,000. Connor Clark and Lunn Investment Management
Read full article